Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Dec 25, 2024; 13(4): 98969
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98969
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98969
Short-term renal and patient outcomes of primary immunoglobulin-associated mesangiocapillary glomerulonephritis: Insights from a developing country
Tabassum Elahi, Saima Ahmed, Department of Nephrology, Sindh Institute of Urology and Transplantation, Karachi 74200, Pakistan
Muhammed Mubarak, Department of Histopathology, Sindh Institute of Urology and Trans plantation, Karachi 74200, Pakistan
Author contributions: Elahi T performed the experiments, analyzed the data, wrote the manuscript with input from all authors; Ahmed S contributed to the interpretation of the results; Mubarak M supervised the project and critically revised and finalized the draft; Elahi T and Ahmed S designed the study; Elahi T and Mubarak M provided critical feedback and helped shape the research, analysis, and manuscript; All authors read and approved the final version of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Sindh Institute of Urology and Transplantation (Pakistan).
Informed consent statement: All study participants or their legal guardians provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare no conflict of interest in publishing the manuscript.
Data sharing statement: The dataset and related documents are available from the corresponding author at elahitabassum@gmail.com.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Muhammed Mubarak, MD, Full Professor, Department of Histopa thology, Sindh Institute of Urology and Transplantation, Chand Bibi Road, Karachi 74200, Pakistan. drmubaraksiut@yahoo.com
Received: July 10, 2024
Revised: September 9, 2024
Accepted: September 19, 2024
Published online: December 25, 2024
Processing time: 119 Days and 23.7 Hours
Revised: September 9, 2024
Accepted: September 19, 2024
Published online: December 25, 2024
Processing time: 119 Days and 23.7 Hours
Core Tip
Core Tip: Primary immunoglobulin (Ig)-associated mesangiocapillary glomerulonephritis (Ig-MCGN) is an immune complex glomerulonephritis of unknown etiology. It is a common cause of chronic kidney disease in developing countries. There is limited data available on renal and patient outcomes from developing countries. In this study, the outcomes of primary Ig-MCGN were guarded and require further prospective studies to improve the understanding of this relatively common disease so that more personalized treatment approaches can be developed.